Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis C
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The study is being done to study the impact of prophylactic administration of antiviral
therapy as compared to initiation of antiviral therapy at the time of clinical recurrence of
hepatitis C infection in liver transplant recipients.